China Jo-Jo Drugstores Reports Fiscal Year 2024 Financial Results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 30 2024
0mins
Source: PRnewswire
Financial Performance Overview: China Jo-Jo Drugstores, Inc. reported a 3.8% increase in revenue to $154.54 million for the fiscal year ending March 31, 2024, driven by a significant 42.1% growth in its wholesale business, despite losses from retail and online pharmacy segments.
Operational Insights: The company achieved a net loss of $4.23 million, a substantial improvement from a $21.14 million loss the previous year, while focusing on enhancing competitive advantages and exploring growth opportunities in China's healthcare market.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
